TY - JOUR
T1 - Clonal evolution from trisomy into tetrasomy of chromosome 8 associated with the development of acute myeloid leukemia from myelodysplastic syndrome
AU - Kameoka, Junichi
AU - Funato, Tadao
AU - Obara, Yasuhiko
AU - Kadowaki, Ikuko
AU - Yokoyama, Hisayuki
AU - Kimura, Tomofumi
AU - Tomiya, Yasuo
AU - Yamada, Minami
AU - Ishikawa, Izumi
AU - Takagawa, Masanori
AU - Sasaki, Osamu
AU - Kimura, Jun
AU - Harigae, Hideo
AU - Miura, Ikuo
AU - Meguro, Kuniaki
AU - Kaku, Mitsuo
AU - Sasaki, Takeshi
PY - 2001/1/15
Y1 - 2001/1/15
N2 - Tetrasomy 8, though rare, is usually associated with trisomy 8, a far more common chromosomal abnormality in acute myeloid leukemia (AML). Yet the clonal relationship between trisomy 8 and tetrasomy 8 in the cases with these chromosomal abnormalities has been unclear. Here, we report a case of a 17-year-old male, diagnosed as having a myelodysplastic syndrome (MDS). Chromosome analysis showed the presence of trisomy 8. Five years later, he developed overt AML exhibiting tetrasomy 8 only. After chemotherapy, the blast cells in the bone marrow decreased to 3.4%, and the karyotype showed trisomy 8 alone. Fluorescence in situ hybridization using a probe specific for chromosome 8 showed that the percentages of cells exhibiting 2/ 3 /4 signals were 7.8/89.2/2.0 at the MDS stage, 20.5/36.1/41.0 when overt AML developed and 24.0/72.1/2.4 after chemotherapy. These results suggested that tetrasomy 8 is derived from the AML clone, possibly evolved from the MDS clone with trisomy 8. To our knowledge, this is the first detailed case report of clonal evolution from trisomy 8 into tetrasomy 8 associated with the development of AML from MDS.
AB - Tetrasomy 8, though rare, is usually associated with trisomy 8, a far more common chromosomal abnormality in acute myeloid leukemia (AML). Yet the clonal relationship between trisomy 8 and tetrasomy 8 in the cases with these chromosomal abnormalities has been unclear. Here, we report a case of a 17-year-old male, diagnosed as having a myelodysplastic syndrome (MDS). Chromosome analysis showed the presence of trisomy 8. Five years later, he developed overt AML exhibiting tetrasomy 8 only. After chemotherapy, the blast cells in the bone marrow decreased to 3.4%, and the karyotype showed trisomy 8 alone. Fluorescence in situ hybridization using a probe specific for chromosome 8 showed that the percentages of cells exhibiting 2/ 3 /4 signals were 7.8/89.2/2.0 at the MDS stage, 20.5/36.1/41.0 when overt AML developed and 24.0/72.1/2.4 after chemotherapy. These results suggested that tetrasomy 8 is derived from the AML clone, possibly evolved from the MDS clone with trisomy 8. To our knowledge, this is the first detailed case report of clonal evolution from trisomy 8 into tetrasomy 8 associated with the development of AML from MDS.
UR - http://www.scopus.com/inward/record.url?scp=0035863016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035863016&partnerID=8YFLogxK
U2 - 10.1016/S0165-4608(00)00347-2
DO - 10.1016/S0165-4608(00)00347-2
M3 - Article
C2 - 11172910
AN - SCOPUS:0035863016
SN - 0165-4608
VL - 124
SP - 159
EP - 164
JO - Cancer Genetics and Cytogenetics
JF - Cancer Genetics and Cytogenetics
IS - 2
ER -